This move is archived. Current quotes and coverage live on the stock page.
Follow ACB
Aurora Cannabis Inc faces a challenging trading session as its stock dips amid mixed market sentiment.
Aurora Cannabis Inc (ACB.TO) is experiencing a downturn today, with shares sliding by 2.81% to close at CA$3.80. This decline comes despite the company recently reporting record annual revenue and adjusted EBITDA, which typically would bolster investor confidence.
Advertisement
Aurora Cannabis Inc
ACB.TO
ACB.TO
Aurora Cannabis Inc
WealthAwesomeMarket cap
$353.27M
52W high
$8.75
52W low
$3.59
1W change
-8.51%
Beta
1.42
Analyst Price Targets
Based on analyst covering ACB · as of Oct 8, 2026
Wall Street analysts forecast ACB stock price to rise 42.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.66
+42.6% Upside
Previously C$5.38 on Sep 17, 2026
Current Price
C$3.97
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ACB's historical volatility
30-Day Vol
53.6%
Annualized
90-Day Vol
56.1%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$6.68
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$5.93 | C$4.93 – C$7.14 |
| 60 trading days | C$6.30 | C$4.85 – C$8.18 |
| 90 trading days | C$6.68 | C$4.85 – C$9.20 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should remain cautious as Aurora's stock continues to face volatility, even in the wake of positive earnings reports.
Aurora Cannabis Inc sees a 2.81% drop in stock value today
The stock's market cap stands at CA$240.3 million, highlighting the company's current valuation amidst fluctuating investor sentiment.
Bull case
Aurora's recent financial results show strong growth, with an 18% year-over-year increase in global medical cannabis net revenue. This indicates a solid demand in the market, which is a positive sign for investors.
Bear case
Despite the positive earnings, the stock's decline today reflects ongoing concerns about profitability and market conditions that could impact future performance.
Advertisement
Market Reaction to Earnings
Despite Aurora Cannabis reporting record annual global medical cannabis net revenue of CA$288.6 million, the stock faced a decline today. Investors may be reacting to broader market conditions or concerns about the company's profitability, as indicated by its negative profit margin of -42.41%.
Future Outlook and Investor Sentiment
Aurora's future remains uncertain as it navigates a competitive landscape. While the company has received support from institutional advisers for its upcoming AGM, investor sentiment may be tempered by the stock's recent performance. Investors should keep an eye on upcoming developments, including the scheduled conference call to discuss Q1 2027 results.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
